$35 - $65 per hour
Machine learning drug discovery & development
Open for applications
Machine learning drug discovery & development
201-500 employees
Open for applications
$35 - $65 per hour
201-500 employees
To bring better drugs faster to the patients who can benefit most, through machine learning and data at scale.
Desirable
The synthetic biology market is rapidly growing, projected to increase from $10.7B in 2021 to over $74.7B by 2031. This growth is fueled by advances in biotechnology and expanding applications in healthcare, agriculture, and energy.
With these rapid advancements, insitro is seizing the opportunity to lead the way. The company is transforming drug discovery by combining machine learning with high-throughput biology. By using AI, insitro aims to overcome the bottlenecks of traditional methods, driving down costs and enabling the development of more effective treatments.
To help it on its mission, insitro recently secured strategic agreements with Eli Lilly for metabolic disease treatments and it also expanded its leadership in AI/ML. With this, the company is surely set to accelerate drug development, promising a future of faster and more effective treatments for patients.
Freddie
Company Specialist at Welcome to the Jungle
28% employee growth in 12 months
Mar 2021
$400m
SERIES C
May 2020
$143m
SERIES B
The East Side, South San Francisco, CA
Daphne Koller
(Founder & CEO)Co-founder of engageli and previously Coursera. They also spent a year at CalicoLabs as the Chief Computing Ofificer and over 18 years at Stanford University as a Professor.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job
View 1 more job at Insitro